Switzerland· 58711002
Toctino 30 mg, Weichkapseln
A alitretinoin product containing alitretinoinum, registered in Switzerland by GlaxoSmithKline AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Alitretinoin is registered in 8 of 19 countries.
Countries holding a registration under ATC D11AH04 (alitretinoin), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 5 of them publish a price we can compare per daily dose
Alitretinoin · ATC D11AH04
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of alitretinoin costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- Switzerland: $17.29 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Alitretinoin · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$17.29
The record
At a glance
Swissmedic (Switzerland)- Active substance
- alitretinoinum
- Manufacturer
- GlaxoSmithKline AG
- Country
- Switzerland (CH)
- ATC code
- D11AH04
- ATC class
- Alitretinoin
- Defined daily dose
- 20 mg, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768058711002130 StkCHF 216.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for alitretinoin.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Alitretinoin · interactions on record
5 records
- 1 severe
- 4 moderate
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Salicylic acidD01AE12moderate
- Porfimer sodiumL01XD01moderate
- MethoxsalenL01XD10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Alitretinoin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAlipalmtin 30 mg zachte capsulesOrifarm Healthcare A/S
- United KingdomAlitretinoin 30mg capsulesEnnogen Healthcare International Ltd
- CanadaHANZEMADR. REDDY'S LABORATORIES INC
- SwedenAlitretinoin Ebb 10 mg Kapsel, mjukEbb Medical AB
- NorwayAlitretinoin OrifarmOrifarm Generics A/S
- FinlandAlitretinoin OrifarmOrifarm Generics A/S
- SpainALITRETINOINA IFC 10 MG CAPSULAS BLANDAS EFGIndustrial Farmaceutica Cantabria S.A.
- FranceALIZEM 10 mg, capsule mollePIERRE FABRE MEDICAMENT
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Alitretan, Toctino
- Belgium · Alitretinoin Orifarm
- Germany · Alitrederm, Toctino
- Denmark · Alitretinoin Orifarm, Toctino
- Spain · Alitretinoína Ifc, Toctino
- Finland · Alitretinoin Orifarm, Toctino
- France · Alizem, Toctino
- United Kingdom (Northern Ireland) · Alitretinoin Ennogen Healthcare, Alitretinoin Ennogen Ip
- Italy · Alitrecare, Toctino
- Netherlands · Alipalmtin, Alitretinoïne Ifc
- Norway · Alitretinoin Orifarm, Toctino
- Portugal · Alitretinoína Cantabria
- Sweden · Alitretinoin Orifarm
- Slovenia · Toctino
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb6fb0d3-80f7-45d1-991f-5a92f7988ca7 GET /v1/drugs/cb6fb0d3-80f7-45d1-991f-5a92f7988ca7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "alitretinoinum 30 mg",
"valid_from": "2009-12-01",
"limitations": "[{\"description\":\"TOCTINO ist indiziert bei Erwachsenen mit schwerem, therapie-refraktärem Handekzem, welches seit mehr als 3 Monaten besteht und auf eine ausgebaute (mindestens 4 Wochen dauernde) topische Behandlung mit potenten Steroiden nicht angesprochen hat. Die Vorbehandlung schliesst die Vermeidung von Kontakten mit der auslösenden Noxe und Hautschutz mit ein.<br>\\nDie Behandlung sollte abgebrochen werden:<br>\\na) wenn sich das Ekzem zufriedenstellend gebessert hat,<br>\\nb) wenn der Patient nach den ersten 12 Wochen immer noch schwere Symptome hat,<br>\\nc) wenn sich das Ekzem nach 24 Wochen nicht wesentlich gebessert hat.<br>\\nTOCTINO darf nur von Dermatologen verschrieben werden.<br>\\n<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2009-12-01\"}]",
"galenic_form": "Kaps 30 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2009-12-01",
"self_retention_pct": 10
}See everything about alitretinoin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.